Morning Briefing
Summaries of health policy coverage from major news organizations
Meningitis Vaccine Showing Success In West Africa
The New York Times reports on the success of a new meningococcal vaccine in West Africa, where very few cases of the disease have been detected in countries that use MenAfriVac, which costs 50 cents per dose.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
